Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

IL-21 is required for optimal antibody production and T cell responses during chronic Toxoplasma gondii infection.

Stumhofer JS, Silver JS, Hunter CA.

PLoS One. 2013 May 7;8(5):e62889. doi: 10.1371/journal.pone.0062889. Print 2013.

2.

Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.

Chen J, Li ZY, Petersen E, Liu WG, Zhu XQ.

Exp Parasitol. 2016 Mar;162:18-23. doi: 10.1016/j.exppara.2015.12.013. Epub 2015 Dec 17.

PMID:
26706605
3.

Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii.

Caamaño J, Tato C, Cai G, Villegas EN, Speirs K, Craig L, Alexander J, Hunter CA.

J Immunol. 2000 Nov 15;165(10):5720-8.

4.

Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5.

Zhang NZ, Huang SY, Xu Y, Chen J, Wang JL, Tian WP, Zhu XQ.

Clin Vaccine Immunol. 2014 Jul;21(7):924-9. doi: 10.1128/CVI.00059-14. Epub 2014 Apr 30.

5.

DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice.

Chen J, Huang SY, Zhou DH, Li ZY, Petersen E, Song HQ, Zhu XQ.

Vaccine. 2013 Dec 16;31(52):6225-31. doi: 10.1016/j.vaccine.2013.10.034. Epub 2013 Oct 31.

PMID:
24183979
6.

IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii.

Wille U, Nishi M, Lieberman L, Wilson EH, Roos DS, Hunter CA.

Parasite Immunol. 2004 May;26(5):229-36.

7.
8.

Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.

Collazo CM, Miller C, Yap G, Hieny S, Caspar P, Schwartz RH, Sher A.

Infect Immun. 2000 May;68(5):2713-9.

9.

Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice.

Chen J, Li ZY, Huang SY, Petersen E, Song HQ, Zhou DH, Zhu XQ.

BMC Infect Dis. 2014 Sep 6;14:487. doi: 10.1186/1471-2334-14-487.

10.
11.

In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.

Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A.

J Immunol. 1996 Jul 15;157(2):798-805.

PMID:
8752931
12.
13.

Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.

Khan IA, Hakak R, Eberle K, Sayles P, Weiss LM, Urban JF Jr.

Infect Immun. 2008 Mar;76(3):1305-13. doi: 10.1128/IAI.01236-07. Epub 2008 Jan 14.

14.

Heat stress-induced modulation of host defense against Toxoplasma gondii infection in mice.

Nishiya K, Norose K, Aosai F, Chen M, Mun HS, Kang HK, Miyazaki M, Yano A.

J Parasitol. 2005 Jun;91(3):702-6.

PMID:
16108573
15.
16.

Toxoplasma gondii-specific CD4+ T cell clones from healthy, latently infected humans display a Th0 profile of cytokine secretion.

Prigione I, Facchetti P, Ghiotto F, Tasso P, Pistoia V.

Eur J Immunol. 1995 May;25(5):1298-305.

PMID:
7774633
17.

Cellular immune responses to recombinant antigens in pregnant women chronically infected with Toxoplasma gondii.

Fatoohi AF, Cozon GJ, Greenland T, Ferrandiz J, Bienvenu J, Picot S, Peyron F.

Clin Diagn Lab Immunol. 2002 May;9(3):704-7.

18.

A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis.

Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA.

J Neuroimmunol. 2005 Aug;165(1-2):63-74.

PMID:
16005735
19.

CCR7-dependent immunity during acute Toxoplasma gondii infection.

Noor S, Habashy AS, Nance JP, Clark RT, Nemati K, Carson MJ, Wilson EH.

Infect Immun. 2010 May;78(5):2257-63. doi: 10.1128/IAI.01314-09. Epub 2010 Mar 1.

20.

Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.

Schlüter D, Kwok LY, Lütjen S, Soltek S, Hoffmann S, Körner H, Deckert M.

J Immunol. 2003 Jun 15;170(12):6172-82.

Supplemental Content

Support Center